Cancer Genetics Company Profile (NASDAQ:CGIX)

About Cancer Genetics

Cancer Genetics logoCancer Genetics, Inc. is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services, and molecular markers. The Company develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment, and enable biopharmaceutical companies engaged in oncology trials to select candidate populations and manage adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. It has a range of disease-focused oncology testing portfolio. Its molecular- and biomarker-based diagnostic services are provided for three sectors: cancer centers and hospitals, biotechnology and biopharmaceutical companies, and the research community.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CGIX
  • CUSIP:
Key Metrics:
  • Previous Close: $1.79
  • 50 Day Moving Average: $2.05
  • 200 Day Moving Average: $2.25
  • 52-Week Range: $1.72 - $8.51
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.75
  • P/E Growth: -0.04
  • Market Cap: $28.85M
  • Outstanding Shares: 16,120,000
  • Beta: 1.08
Profitability:
  • Net Margins: -89.60%
  • Return on Equity: -72.29%
  • Return on Assets: -47.11%
Debt:
  • Debt-to-Equity Ratio: 0.13%
  • Current Ratio: 2.42%
  • Quick Ratio: 2.42%
Additional Links:
Companies Related to Cancer Genetics:

Analyst Ratings

Consensus Ratings for Cancer Genetics (NASDAQ:CGIX) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $9.00 (402.79% upside)

Analysts' Ratings History for Cancer Genetics (NASDAQ:CGIX)
Show:
DateFirmActionRatingPrice TargetDetails
9/27/2016HC WainwrightInitiated CoverageBuy$6.00View Rating Details
9/26/2016Rodman & RenshawInitiated CoverageBuy$6.00View Rating Details
3/15/2016AegisBoost Price TargetBuy$8.00 -> $15.00View Rating Details
3/11/2016Janney Montgomery ScottReiterated RatingBuy -> NeutralView Rating Details
5/14/2015Cantor FitzgeraldReiterated RatingBuy$13.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Cancer Genetics (NASDAQ:CGIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/10/2016Q216($0.33)($0.28)$6.50 million$7.00 millionViewN/AView Earnings Details
5/10/2016Q1($0.43)($0.39)$6.95 million$6.10 millionViewListenView Earnings Details
3/10/2016Q415($0.46)($0.48)$7.00 million$5.50 millionViewListenView Earnings Details
11/10/2015Q315($0.49)($0.56)$5.13 million$4.00 millionViewListenView Earnings Details
8/11/2015Q215($0.50)($0.51)$4.67 million$4.20 millionViewListenView Earnings Details
5/12/2015Q115($0.54)($0.44)$3.91 million$4.40 millionViewListenView Earnings Details
3/12/2015Q414($0.50)($0.49)$3.70 million$4.00 millionViewN/AView Earnings Details
11/10/2014($0.51)($0.41)ViewN/AView Earnings Details
8/14/2014Q214($0.37)($0.50)$2.13 million$3.20 millionViewN/AView Earnings Details
5/15/2014Q114($0.29)($0.27)$2.17 million$1.40 millionViewN/AView Earnings Details
3/26/2014Q4 13($0.36)($0.37)$1.95 million$1.90 millionViewN/AView Earnings Details
11/13/2013Q313($0.71)($0.61)$1.60 million$1.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cancer Genetics (NASDAQ:CGIX)
Current Year EPS Consensus Estimate: $-1.17 EPS
Next Year EPS Consensus Estimate: $-0.65 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.38)($0.28)($0.33)
Q2 20161($0.33)($0.33)($0.33)
Q3 20161($0.29)($0.29)($0.29)
Q4 20161($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cancer Genetics (NASDAQ:CGIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cancer Genetics (NASDAQ:CGIX)
Insider Ownership Percentage: 25.40%
Institutional Ownership Percentage: 9.65%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/16/2016John PappajohnDirectorBuy45,000$2.29$103,050.00View SEC Filing  
8/15/2016John PappajohnDirectorBuy147,500$2.16$318,600.00View SEC Filing  
3/17/2016John PappajohnDirectorBuy50,000$2.64$132,000.00View SEC Filing  
3/17/2016Panna SharmaCEOBuy1,500$2.59$3,885.00View SEC Filing  
3/16/2016John PappajohnDirectorBuy100,000$2.53$253,000.00View SEC Filing  
3/15/2016Panna SharmaCEOBuy1,000$2.56$2,560.00View SEC Filing  
8/27/2015John PappajohnDirectorBuy5,000$9.61$48,050.00View SEC Filing  
6/25/2015Raju S.K. ChagantiDirectorSell5,296$12.00$63,552.00View SEC Filing  
6/12/2015Raju S.K. ChagantiDirectorSell7,000$12.01$84,070.00View SEC Filing  
6/11/2015Raju S.K. ChagantiDirectorSell46,454$12.03$558,841.62View SEC Filing  
6/8/2015Raju S.K. ChagantiDirectorSell24,583$12.03$295,733.49View SEC Filing  
5/14/2015John PappajohnDirectorBuy5,000$10.74$53,700.00View SEC Filing  
3/17/2015John PappajohnDirectorBuy50,000$7.36$368,000.00View SEC Filing  
3/16/2015Edward J SitarCFOBuy1,000$6.99$6,990.00View SEC Filing  
12/16/2014John PappajohnDirectorBuy5,589$6.20$34,651.80View SEC Filing  
12/15/2014John PappajohnDirectorBuy3,634$6.14$22,312.76View SEC Filing  
12/11/2014John PappajohnDirectorBuy27,087$6.03$163,334.61View SEC Filing  
12/10/2014John PappajohnDirectorBuy5,773$5.96$34,407.08View SEC Filing  
12/9/2014John PappajohnDirectorBuy39,686$5.35$212,320.10View SEC Filing  
5/21/2014Edward SitarCFOBuy1,000$10.67$10,670.00View SEC Filing  
5/21/2014John PappajohnDirectorBuy50,000$10.31$515,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cancer Genetics (NASDAQ:CGIX)
DateHeadline
News IconInterested Penny Stock Investors Keen on Shares of Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX)
www.duncanindependent.com - September 28 at 4:03 PM
4-traders.com logoCancer Genetics : Announces $5.5 Million Registered Direct Offering (NASDAQ:CGIX)
www.4-traders.com - September 28 at 9:01 AM
4-traders.com logoCancer Genetics : to Present at Two Upcoming Investor Conferences During September (NASDAQ:CGIX)
www.4-traders.com - September 27 at 4:09 PM
publicnow.com logoCancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive Clinical Trial and Companion Diagnostic Solutions for the Oncology Industry (NASDAQ:CGIX)
www.publicnow.com - September 27 at 4:09 PM
News IconStock Noted Gapping Up Pre-Market: Cancer Genetics, Inc. (NASDAQ:CGIX) - Post News (NASDAQ:CGIX)
www.kentuckypostnews.com - September 27 at 8:46 AM
investornewswire.com logoCancer Genetics, Inc. (NASDAQ:CGIX) To Hit Price Target Of $5.75? - Investor Newswire (NASDAQ:CGIX)
www.investornewswire.com - September 27 at 8:46 AM
benzinga.com logoRodman & Renshaw Prescribe A $6 Price Target For Cancer Genetics (NASDAQ:CGIX)
www.benzinga.com - September 26 at 4:25 PM
streetinsider.com logoCancer Genetics (CGIX), ApoCell Enter Strategic Partnership for Circulating Tumor Cells (NASDAQ:CGIX)
www.streetinsider.com - September 26 at 8:57 AM
finance.yahoo.com logoCancer Genetics, Inc. and ApoCell Announce Partnership Focused on Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform for Rare Cell Capture and Detection (NASDAQ:CGIX)
finance.yahoo.com - September 26 at 8:57 AM
News IconKeen Investors Find News on Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX)
www.duncanindependent.com - September 24 at 8:25 AM
News IconUnder the Microscope, Zeroing in at Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX)
www.duncanindependent.com - September 22 at 4:22 PM
News IconCancer Genetics Inc's (NASDAQ:CGIX) Partnership With BARC Will Enhance Effective Delivery Of Solutions In The ... - Scibility Media (NASDAQ:CGIX)
scibilitymedia.com - September 22 at 4:22 PM
News IconCancer Genetics, Inc. Announces a Global Partnership with [..] (NASDAQ:CGIX)
www.pr-inside.com - September 21 at 4:49 PM
News IconPenny Stock Investors Take an Interest in Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX)
www.duncanindependent.com - September 21 at 8:13 AM
finance.yahoo.com logoCancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive ... - Yahoo Finance (NASDAQ:CGIX)
finance.yahoo.com - September 21 at 8:13 AM
globenewswire.com logoCancer Genetics, Inc. to Present at Two Upcoming Investor Conferences During September - GlobeNewswire (press release) (NASDAQ:CGIX)
www.globenewswire.com - September 21 at 8:13 AM
finance.yahoo.com logoCancer Genetics, Inc. to Present at Two Upcoming Investor Conferences During September (NASDAQ:CGIX)
finance.yahoo.com - September 21 at 8:13 AM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CGIX)
biz.yahoo.com - September 17 at 8:56 AM
streetinsider.com logoCancer Genetics (CGIX) Enters 2.75M Share Registered Direct Offering (NASDAQ:CGIX)
www.streetinsider.com - September 10 at 3:59 PM
4-traders.com logoCancer Genetics : to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:CGIX)
www.4-traders.com - September 9 at 4:03 PM
nasdaq.com logoCancer Genetics, Inc. to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:CGIX)
m.nasdaq.com - September 9 at 4:03 PM
streetinsider.com logoCancer Genetics (CGIX) Enters 2.75M Share Registered Direct Offering - StreetInsider.com (NASDAQ:CGIX)
www.streetinsider.com - September 9 at 9:00 AM
globenewswire.com logoCancer Genetics, Inc. to Present at the Rodman & Renshaw 18th Annual Global Investment Conference - GlobeNewswire (press release) (NASDAQ:CGIX)
globenewswire.com - September 9 at 9:00 AM
finance.yahoo.com logoCancer Genetics Announces $5.5 Million Registered Direct Offering (NASDAQ:CGIX)
finance.yahoo.com - September 9 at 9:00 AM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu (NASDAQ:CGIX)
biz.yahoo.com - September 9 at 9:00 AM
capitalcube.com logoETF’s with exposure to Cancer Genetics, Inc. : August 29, 2016 (NASDAQ:CGIX)
www.capitalcube.com - August 29 at 3:34 PM
finance.yahoo.com logoCANCER GENETICS, INC Financials (NASDAQ:CGIX)
finance.yahoo.com - August 19 at 4:50 PM
News IconCancer Genetics, Inc.'s (CGIX): Really worthy Stock of Yesterday - Hot Stocks Point (NASDAQ:CGIX)
www.hotstockspoint.com - August 18 at 4:12 PM
News IconRecent Insider Activity: Cancer Genetics (CGIX) - The Voice Registrar (NASDAQ:CGIX)
voiceregistrar.com - August 18 at 4:12 PM
streetinsider.com logoCancer Genetics' (CGIX) Focus::Myeloid NGS-Based Panel Receives Approval in New York State (NASDAQ:CGIX)
www.streetinsider.com - August 18 at 11:41 AM
News IconStock Gapping Up Pre-Market: Cancer Genetics, Inc. (NASDAQ:CGIX) - Post News (NASDAQ:CGIX)
www.kentuckypostnews.com - August 17 at 4:19 PM
News IconCancer Genetics, Inc. Strengthens Position as a Leader in Myeloid Cancer Diagnosis and Management Receiving New York State Approval for… (NASDAQ:CGIX)
forextv.com - August 17 at 11:46 AM
finance.yahoo.com logoCancer Genetics, Inc. Strengthens Position as a Leader in Myeloid Cancer Diagnosis and Management Receiving New York State Approval for Focus::Myeloid™, a Targeted NGS Panel for Improved Diagnosis, Risk Stratification, and Therapy Selection (NASDAQ:CGIX)
finance.yahoo.com - August 17 at 11:46 AM
finance.yahoo.com logo7:31 am Cancer Genetics receives NY State approval for its Focus::Myeloid NGS-based panel for myeloid malignancies including acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms (NASDAQ:CGIX)
finance.yahoo.com - August 17 at 11:46 AM
capitalcube.com logoETF’s with exposure to Cancer Genetics, Inc. : August 15, 2016 (NASDAQ:CGIX)
www.capitalcube.com - August 15 at 11:26 AM
capitalcube.com logoCancer Genetics, Inc. :CGIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:CGIX)
www.capitalcube.com - August 12 at 12:16 PM
News IconCancer Genetics Inc. (NASDAQ: CGIX) reports quarterly earnings - BNB Daily (blog) (NASDAQ:CGIX)
www.baseball-news-blog.com - August 11 at 11:58 AM
finance.yahoo.com logoCancer Genetics reports 2Q loss - Yahoo Finance (NASDAQ:CGIX)
finance.yahoo.com - August 10 at 4:13 PM
nasdaq.com logoCancer Genetics, Inc. Reports Second Quarter 2016 Financial Results and Provides Company Updates (NASDAQ:CGIX)
www.nasdaq.com - August 9 at 9:58 PM
sg.finance.yahoo.com logoCancer Genetics reports 2Q loss (NASDAQ:CGIX)
sg.finance.yahoo.com - August 9 at 9:58 PM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 10-Q, Quarterly Report (NASDAQ:CGIX)
biz.yahoo.com - August 9 at 4:28 PM
globenewswire.com logoCancer Genetics to Report Second Quarter Earnings on Wednesday, August 10 - GlobeNewswire (press release) (NASDAQ:CGIX)
globenewswire.com - August 2 at 4:16 PM
ftsenews.co.uk logoNew Broker Ratings For Cancer Genetics, Inc. (CGIX) - FTSE News (NASDAQ:CGIX)
www.ftsenews.co.uk - August 2 at 4:16 PM
finance.yahoo.com logoCancer Genetics to Report Second Quarter Earnings on Wednesday, August 10 (NASDAQ:CGIX)
finance.yahoo.com - August 2 at 8:58 AM
News IconShares Stumbling of Late: Cancer Genetics, Inc. (NASDAQ:CGIX) - TGP (NASDAQ:CGIX)
telanaganapress.com - July 23 at 4:08 PM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 8-K, Shareholder Director Nominations (NASDAQ:CGIX)
biz.yahoo.com - July 22 at 4:05 PM
News IconInsiders Increasing Positions in: Cancer Genetics, Inc. (NASDAQ:CGIX) - Press Telegraph (NASDAQ:CGIX)
presstelegraph.com - July 22 at 12:20 PM
news.cmlviz.com logoCancer Genetics Inc (NASDAQ:CGIX) Stock Technicals at Critical Inflection Point - CML News (NASDAQ:CGIX)
news.cmlviz.com - July 22 at 12:20 PM
finance.yahoo.com logoCancer Genetics Inc. Selected by H3 Biomedicine Inc., to Provide Biomarker Discovery and Testing for a Global Drug ... - Yahoo Finance (NASDAQ:CGIX)
finance.yahoo.com - July 19 at 4:13 PM
news.cmlviz.com logoCancer Genetics, Inc. (NasdaqCM:CGIX) Fundamental Star Rating Report - CML News (NASDAQ:CGIX)
news.cmlviz.com - July 19 at 4:13 PM

Social

Cancer Genetics (NASDAQ:CGIX) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff